Skip Navigation

Receive this page by email each issue: [Sign up for eTOCs]

Cover Image
Other Issues:
Previous
Contents: Volume 64, Number 1, July 2009   [Index by Author] 

Down Leading articles
Down Review
Down Systematic review
Down Original research
Down Research letters
Down Letters to the Editor


[Search ALL Issues]


Front Matter (PDF) | Table of Contents (PDF)

To see an article, click its [Full Text] or [PDF] link. To review many abstracts, check the boxes to the left of the titles you want, and click the 'Get All Checked Abstract(s)' button. To see one abstract at a time, click its [Abstract] link.

Leading articles Back

Stephan Ludwig
Targeting cell signalling pathways to fight the flu: towards a paradigm change in anti-influenza therapy
JAC Advance Access published on May 6, 2009
J. Antimicrob. Chemother. 2009 64: 1-4; doi:10.1093/jac/dkp161 [Abstract] [FREE Full Text] [PDF] [Request Permissions]  

Kay Seden, David Back, and Saye Khoo
Antiretroviral drug interactions: often unrecognized, frequently unavoidable, sometimes unmanageable
JAC Advance Access published on April 27, 2009
J. Antimicrob. Chemother. 2009 64: 5-8; doi:10.1093/jac/dkp152 [Abstract] [FREE Full Text] [PDF] [Request Permissions]  

Review Back

T. Coates, R. Bax, and A. Coates
Nasal decolonization of Staphylococcus aureus with mupirocin: strengths, weaknesses and future prospects
JAC Advance Access published on May 18, 2009
J. Antimicrob. Chemother. 2009 64: 9-15; doi:10.1093/jac/dkp159 [Abstract] [FREE Full Text] [PDF]   Creative Commons License OPEN ACCESS  

Systematic review Back

Evridiki K. Vouloumanou, Drosos E. Karageorgopoulos, Maria S. Kazantzi, Anastasios M. Kapaskelis, and Matthew E. Falagas
Antibiotics versus placebo or watchful waiting for acute otitis media: a meta-analysis of randomized controlled trials
JAC Advance Access published on May 19, 2009
J. Antimicrob. Chemother. 2009 64: 16-24; doi:10.1093/jac/dkp166 [Abstract] [Full Text] [PDF] [Supplementary Data] [Request Permissions]  

Original research Back

Nadine Sichtig, Saleta Sierra, Rolf Kaiser, Martin Däumer, Stefan Reuter, Eugen Schülter, Andre Altmann, Gerd Fätkenheuer, Ulf Dittmer, Herbert Pfister, and Stefan Esser
Evolution of raltegravir resistance during therapy
JAC Advance Access published on May 14, 2009
J. Antimicrob. Chemother. 2009 64: 25-32; doi:10.1093/jac/dkp153 [Abstract] [Full Text] [PDF] [Request Permissions]  

J. Gerardo García-Lerma, Amanda McNulty, Cheryl Jennings, Diana Huang, Walid Heneine, and James W. Bremer
Rapid decline in the efficiency of HIV drug resistance genotyping from dried blood spots (DBS) and dried plasma spots (DPS) stored at 37°C and high humidity
JAC Advance Access published on April 29, 2009
J. Antimicrob. Chemother. 2009 64: 33-36; doi:10.1093/jac/dkp150 [Abstract] [Full Text] [PDF] [Request Permissions]  

Arabela Cuirolo, Konrad Plata, and Adriana E. Rosato
Development of homogeneous expression of resistance in methicillin-resistant Staphylococcus aureus clinical strains is functionally associated with a β-lactam-mediated SOS response
JAC Advance Access published on May 20, 2009
J. Antimicrob. Chemother. 2009 64: 37-45; doi:10.1093/jac/dkp164 [Abstract] [Full Text] [PDF] [Supplementary Data] [Request Permissions]  

Syuntaro Kouda, Masaru Ohara, Makoto Onodera, Yoshihiro Fujiue, Megumi Sasaki, Tadahiro Kohara, Seiya Kashiyama, Shizue Hayashida, Toshie Harino, Takahiro Tsuji, Hideyuki Itaha, Naomasa Gotoh, Akio Matsubara, Tsuguru Usui, and Motoyuki Sugai
Increased prevalence and clonal dissemination of multidrug-resistant Pseudomonas aeruginosa with the blaIMP-1 gene cassette in Hiroshima
JAC Advance Access published on April 27, 2009
J. Antimicrob. Chemother. 2009 64: 46-51; doi:10.1093/jac/dkp142 [Abstract] [Full Text] [PDF] [Supplementary Data] [Request Permissions]  

O. Peuchant, A. Ménard, H. Renaudin, M. Morozumi, K. Ubukata, C. M. Bébéar, and S. Pereyre
Increased macrolide resistance of Mycoplasma pneumoniae in France directly detected in clinical specimens by real-time PCR and melting curve analysis
JAC Advance Access published on May 9, 2009
J. Antimicrob. Chemother. 2009 64: 52-58; doi:10.1093/jac/dkp160 [Abstract] [Full Text] [PDF] [Request Permissions]  

C. K. Hope, S. Packer, M. Wilson, and S. P. Nair
The inability of a bacteriophage to infect Staphylococcus aureus does not prevent it from specifically delivering a photosensitizer to the bacterium enabling its lethal photosensitization
JAC Advance Access published on May 2, 2009
J. Antimicrob. Chemother. 2009 64: 59-61; doi:10.1093/jac/dkp157 [Abstract] [Full Text] [PDF] [Request Permissions]  

Lucia Granieri, Oliver J. Miller, Andrew D. Griffiths, and Christoph A. Merten
A competition-based assay for the screening of species-specific antibiotics
JAC Advance Access published on April 28, 2009
J. Antimicrob. Chemother. 2009 64: 62-68; doi:10.1093/jac/dkp137 [Abstract] [Full Text] [PDF] [Request Permissions]  

M. Casal, F. Rodríguez, B. Johnson, E. Garduno, F. Tubau, R. Ortiz de Lejarazu, A. Tenorio, M. J. Giménez, R. Bartolomé, C. Garcia-Rey, L. Aguilar, and N. García-Escribano
Influence of testing methodology on the tigecycline activity profile against presumably tigecycline-non-susceptible Acinetobacter spp.
JAC Advance Access published on May 17, 2009
J. Antimicrob. Chemother. 2009 64: 69-72; doi:10.1093/jac/dkp169 [Abstract] [Full Text] [PDF] [Request Permissions]  

Chih-Cheng Lai, Che-Kim Tan, Sheng Hsiang Lin, Chun-Hsing Liao, Chien-Hong Chou, Hsiao-Leng Hsu, Yu-Tsung Huang, and Po-Ren Hsueh
Comparative in vitro activities of nemonoxacin, doripenem, tigecycline and 16 other antimicrobials against Nocardia brasiliensis, Nocardia asteroides and unusual Nocardia species
JAC Advance Access published on April 27, 2009
J. Antimicrob. Chemother. 2009 64: 73-78; doi:10.1093/jac/dkp144 [Abstract] [Full Text] [PDF] [Supplementary Data] [Request Permissions]  

George R. Thompson, III, Nathan P. Wiederhold, Deanna A. Sutton, Annette Fothergill, and Thomas F. Patterson
In vitro activity of isavuconazole against Trichosporon, Rhodotorula, Geotrichum, Saccharomyces and Pichia species
JAC Advance Access published on April 30, 2009
J. Antimicrob. Chemother. 2009 64: 79-83; doi:10.1093/jac/dkp138 [Abstract] [Full Text] [PDF] [Request Permissions]  

Elisalva T. Guimarães, Milena S. Lima, Luana A. Santos, Ivone M. Ribeiro, Therezinha B. C. Tomassini, Ricardo Ribeiro dos Santos, Washington L. C. dos Santos, and Milena B. P. Soares
Activity of physalins purified from Physalis angulata in in vitro and in vivo models of cutaneous leishmaniasis
JAC Advance Access published on May 19, 2009
J. Antimicrob. Chemother. 2009 64: 84-87; doi:10.1093/jac/dkp170 [Abstract] [Full Text] [PDF] [Request Permissions]  

Rabih O. Darouiche, Mohammad D. Mansouri, Purushottam V. Gawande, and Srinivasa Madhyastha
Antimicrobial and antibiofilm efficacy of triclosan and DispersinB® combination
JAC Advance Access published on May 14, 2009
J. Antimicrob. Chemother. 2009 64: 88-93; doi:10.1093/jac/dkp158 [Abstract] [Full Text] [PDF] [Request Permissions]  

John F. Kokai-Kun, Tanya Chanturiya, and James J. Mond
Lysostaphin eradicates established Staphylococcus aureus biofilms in jugular vein catheterized mice
JAC Advance Access published on April 27, 2009
J. Antimicrob. Chemother. 2009 64: 94-100; doi:10.1093/jac/dkp145 [Abstract] [Full Text] [PDF] [Supplementary Data] [Request Permissions]  

Pavel Gershkovich, Ellen K. Wasan, Molly Lin, Olena Sivak, Carlos G. Leon, John G. Clement, and Kishor M. Wasan
Pharmacokinetics and biodistribution of amphotericin B in rats following oral administration in a novel lipid-based formulation
JAC Advance Access published on April 27, 2009
J. Antimicrob. Chemother. 2009 64: 101-108; doi:10.1093/jac/dkp140 [Abstract] [Full Text] [PDF] [Request Permissions]  

Massimiliano Fabbiani, Simona Di Giambenedetto, Laura Bracciale, Alessandra Bacarelli, Enzo Ragazzoni, Roberto Cauda, Pierluigi Navarra, and Andrea De Luca
Pharmacokinetic variability of antiretroviral drugs and correlation with virological outcome: 2 years of experience in routine clinical practice
JAC Advance Access published on April 27, 2009
J. Antimicrob. Chemother. 2009 64: 109-117; doi:10.1093/jac/dkp132 [Abstract] [Full Text] [PDF] [Request Permissions]  

Roland Landman, Catherine Capitant, Diane Descamps, Corine Chazallon, Gilles Peytavin, Christine Katlama, Gilles Pialoux, Michelle Bentata, Francoise Brun-Vézinet, Jean-Pierre Aboulker, Patrick Yéni, and on behalf of the ANRS 127 study group
Efficacy and safety of ritonavir-boosted dual protease inhibitor therapy in antiretroviral-naive HIV-1-infected patients: the 2IP ANRS 127 study
JAC Advance Access published on May 6, 2009
J. Antimicrob. Chemother. 2009 64: 118-125; doi:10.1093/jac/dkp146 [Abstract] [Full Text] [PDF] [Request Permissions]  

Pierre-Marie Girard, André Cabié, Christian Michelet, Renaud Verdon, Christine Katlama, Patrick Mercié, Laurence Morand-Joubert, Pascal Pétour, Françoise Monchecourt, Geneviève Chêne, Aldo Trylesinski, and on behalf of the COOL Study Team
A randomized trial of two-drug versus three-drug tenofovir-containing maintenance regimens in virologically controlled HIV-1 patients
JAC Advance Access published on April 29, 2009
J. Antimicrob. Chemother. 2009 64: 126-134; doi:10.1093/jac/dkp141 [Abstract] [Full Text] [PDF] [Request Permissions]  

Pierre Frange, Julie Galimand, Cécile Goujard, Christiane Deveau, Jade Ghosn, Christine Rouzioux, Laurence Meyer, and Marie-Laure Chaix
High frequency of X4/DM-tropic viruses in PBMC samples from patients with primary HIV-1 subtype-B infection in 1996–2007: the French ANRS CO06 PRIMO Cohort Study
JAC Advance Access published on May 2, 2009
J. Antimicrob. Chemother. 2009 64: 135-141; doi:10.1093/jac/dkp151 [Abstract] [Full Text] [PDF] [Request Permissions]  

Jason A. Roberts, Carl M. J. Kirkpatrick, Michael S. Roberts, Thomas A. Robertson, Andrew J. Dalley, and Jeffrey Lipman
Meropenem dosing in critically ill patients with sepsis and without renal dysfunction: intermittent bolus versus continuous administration? Monte Carlo dosing simulations and subcutaneous tissue distribution
JAC Advance Access published on April 27, 2009
J. Antimicrob. Chemother. 2009 64: 142-150; doi:10.1093/jac/dkp139 [Abstract] [Full Text] [PDF] [Supplementary Data] [Request Permissions]  

Abhijit Chakraborty, Sandip Roy, Juergen Loeffler, and Ricardo L. Chaves
Comparison of the pharmacokinetics, safety and tolerability of daptomycin in healthy adult volunteers following intravenous administration by 30 min infusion or 2 min injection
JAC Advance Access published on April 22, 2009
J. Antimicrob. Chemother. 2009 64: 151-158; doi:10.1093/jac/dkp155 [Abstract] [FREE Full Text] [PDF] [Supplementary Data]   Creative Commons License OPEN ACCESS  

Stefan Krüger, Santiago Ewig, Jan Kunde, Alexa Hanschmann, Reinhard Marre, Norbert Suttorp, Tobias Welte, and on behalf of the CAPNETZ study group
C-terminal provasopressin (copeptin) in patients with community-acquired pneumonia—influence of antibiotic pre-treatment: results from the German competence network CAPNETZ
JAC Advance Access published on April 29, 2009
J. Antimicrob. Chemother. 2009 64: 159-162; doi:10.1093/jac/dkp148 [Abstract] [Full Text] [PDF] [Request Permissions]  

Annette S. Bukh, Henrik C. Schønheyder, Jeppe M. G. Emmersen, Mette Søgaard, Søren Bastholm, and Peter Roslev
Escherichia coli phylogenetic groups are associated with site of infection and level of antibiotic resistance in community-acquired bacteraemia: a 10 year population-based study in Denmark
JAC Advance Access published on May 8, 2009
J. Antimicrob. Chemother. 2009 64: 163-168; doi:10.1093/jac/dkp156 [Abstract] [Full Text] [PDF] [Supplementary Data] [Request Permissions]  

Majdi N. Al-Hasan, Brian D. Lahr, Jeanette E. Eckel-Passow, and Larry M. Baddour
Antimicrobial resistance trends of Escherichia coli bloodstream isolates: a population-based study, 1998–2007
JAC Advance Access published on May 12, 2009
J. Antimicrob. Chemother. 2009 64: 169-174; doi:10.1093/jac/dkp162 [Abstract] [Full Text] [PDF] [Request Permissions]  

Vidya Mave, Julia Garcia-Diaz, Tareq Islam, and Rodrigo Hasbun
Vancomycin-resistant enterococcal bacteraemia: is daptomycin as effective as linezolid?
JAC Advance Access published on May 7, 2009
J. Antimicrob. Chemother. 2009 64: 175-180; doi:10.1093/jac/dkp154 [Abstract] [Full Text] [PDF] [Request Permissions]  

Elspeth Lamont, R. Andrew Seaton, Merran Macpherson, Lindsay Semple, Emma Bell, and Alison H. Thomson
Development of teicoplanin dosage guidelines for patients treated within an outpatient parenteral antibiotic therapy (OPAT) programme
JAC Advance Access published on May 2, 2009
J. Antimicrob. Chemother. 2009 64: 181-187; doi:10.1093/jac/dkp147 [Abstract] [Full Text] [PDF] [Request Permissions]  

Dominik Mertz, Michael Koller, Patricia Haller, Markus L. Lampert, Herbert Plagge, Balthasar Hug, Gian Koch, Manuel Battegay, Ursula Flückiger, and Stefano Bassetti
Outcomes of early switching from intravenous to oral antibiotics on medical wards
JAC Advance Access published on April 28, 2009
J. Antimicrob. Chemother. 2009 64: 188-199; doi:10.1093/jac/dkp131 [Abstract] [FREE Full Text] [PDF]   Creative Commons License OPEN ACCESS  

Samuel Coenen, Arno Muller, Niels Adriaenssens, Vanessa Vankerckhoven, Erik Hendrickx, and Herman Goossens on behalf of the ESAC Project Group
European Surveillance of Antimicrobial Consumption (ESAC): outpatient parenteral antibiotic treatment in Europe
JAC Advance Access published on April 21, 2009
J. Antimicrob. Chemother. 2009 64: 200-205; doi:10.1093/jac/dkp135 [Abstract] [Full Text] [PDF] [Supplementary Data] [Request Permissions]  

Research letters Back

Apostolos Liakopoulos, Charalambos Neocleous, Dimitra Klapsa, Maria Kanellopoulou, Iris Spiliopoulou, Kostas D. Mathiopoulos, Evangelos Papafrangas, and Efi Petinaki
A T2504A mutation in the 23S rRNA gene responsible for high-level resistance to linezolid of Staphylococcus epidermidis
JAC Advance Access published on May 9, 2009
J. Antimicrob. Chemother. 2009 64: 206-207; doi:10.1093/jac/dkp167 [Extract] [Full Text] [PDF] [Request Permissions]  

Rikke D. Bergenholtz, Mikael S. Jørgensen, Lars H. Hansen, Lars B. Jensen, and Henrik Hasman
Characterization of genetic determinants of extended-spectrum cephalosporinases (ESCs) in Escherichia coli isolates from Danish and imported poultry meat
JAC Advance Access published on May 19, 2009
J. Antimicrob. Chemother. 2009 64: 207-209; doi:10.1093/jac/dkp168 [Extract] [Full Text] [PDF] [Request Permissions]  

Ian Morrissey, Don Biek, and Regina Janes
ME1036, a novel carbapenem, with enhanced activity against clinical isolates causing bacteraemic community-acquired pneumonia
JAC Advance Access published on May 9, 2009
J. Antimicrob. Chemother. 2009 64: 209-210; doi:10.1093/jac/dkp163 [Extract] [Full Text] [PDF] [Request Permissions]  

Eliette Touati, Valérie Michel, Marta Correia, Luigi Menghini, Salvatore Genovese, Massimo Curini, and Francesco Epifano
Boropinic acid, a novel inhibitor of Helicobacter pylori stomach colonization
JAC Advance Access published on April 22, 2009
J. Antimicrob. Chemother. 2009 64: 210-211; doi:10.1093/jac/dkp136 [Extract] [Full Text] [PDF] [Request Permissions]  

Letters to the Editor Back

Karen Bush, George A. Jacoby, Gianfranco Amicosante, Robert A. Bonomo, Patricia Bradford, Giuseppe Cornaglia, Javier Garau, Helen Giamarellou, Vincent Jarlier, Luis Martinez-Martinez, Vivi Miriagou, Timothy Palzkill, Alvaro Pascual, Jesus Rodriguez-Baño, Gian Maria Rossolini, Wladimir Sougakoff, and Alkiviadis Vatopoulos
Comment on: Redefining extended-spectrum β-lactamases: balancing science and clinical need
JAC Advance Access published on March 24, 2009
J. Antimicrob. Chemother. 2009 64: 212-213; doi:10.1093/jac/dkp104 [Extract] [Full Text] [PDF] [Request Permissions]  

Christian G. Giske, Arnfinn S. Sundsfjord, Gunnar Kahlmeter, Neil Woodford, Patrice Nordmann, David L. Paterson, Rafael Cantón, and Timothy R. Walsh
Redefining extended-spectrum β-lactamases: balancing science and clinical need—authors’ response
JAC Advance Access published on April 29, 2009
J. Antimicrob. Chemother. 2009 64: 213-215; doi:10.1093/jac/dkp143 [Extract] [Full Text] [PDF] [Request Permissions]  

Massimiliano Lanzafame, Emanuela Lattuada, and Fabiana Corsini
Comment on: Unboosted fosamprenavir is associated with low drug exposure in HIV-infected patients with mild–moderate liver impairment resulting from HCV-related cirrhosis
JAC Advance Access published on March 24, 2009
J. Antimicrob. Chemother. 2009 64: 215-216; doi:10.1093/jac/dkp105 [Extract] [Full Text] [PDF] [Request Permissions]  

Francesca Gatti, Massimo Puoti, Paola Nasta, Saverio G. Parisi, and Giampiero Carosi
Unboosted fosamprenavir is associated with low drug exposure in HIV-infected patients with mild–moderate liver impairment resulting from HCV-related cirrhosis—authors’ response
JAC Advance Access published on April 29, 2009
J. Antimicrob. Chemother. 2009 64: 216; doi:10.1093/jac/dkp149 [Extract] [Full Text] [PDF] [Request Permissions]  

To see an article, click its [Full Text] or [PDF] link. To review many abstracts, check the boxes to the left of the titles you want, and click the 'Get All Checked Abstract(s)' button. To see one abstract at a time, click its [Abstract] link.